Fundz

Bioventrix® Closes $48.5 Million Series A Financing

PRIVATEApr 13, 2023

Amount Raised

$48.5 Million

Round Type

Series A

MansfieldOtherMedical

Investors

Richmond BrothersSquarepoint CapitalTaglich Brothers Inc.Cormorant Asset ManagementAndera Partners

Description

BioVentrix, Inc., a privately held medical device company developing minimally invasive therapies to directly treat the dilated left ventricle and reverse the left ventricular remodeling process in patients with congestive heart failure, today announced the completion of $48.5 million Series A round financing.

Quick answer

BioVentrix raised $48.5 Million in a Series A round, dated April 13, 2023. Investors: Richmond Brothers, Squarepoint Capital, Taglich Brothers Inc., Cormorant Asset Management and Andera Partners. BioVentrix is based in Mansfield, Massachusetts, United States.

How much did BioVentrix raise?
BioVentrix raised $48.5 Million in a Series A round on April 13, 2023.
Who invested in BioVentrix?
Richmond Brothers, Squarepoint Capital, Taglich Brothers Inc., Cormorant Asset Management and Andera Partners are named as investors in this round.
What does BioVentrix do?
BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA.
Where is BioVentrix based and how big is it?
BioVentrix is based in Mansfield, Massachusetts, United States. Fundz records about 20 employees.
Who are the decision-makers at BioVentrix?
Fundz holds 2 contacts at BioVentrix, including the Director of Quality. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical around the same time

Companies in the same sectors as BioVentrix that raised within 45 days of this round, from Fundz verified event records.

  • Conformal Medical raised $35M on May 26, 2023.
  • Renibus Therapeutics raised $64M on May 25, 2023.
  • Qnovia raised $2.9M on May 25, 2023.
  • Patient21 raised $108M (Funding Round) on May 22, 2023.
  • VERTOS MEDICAL INC raised $45M on May 22, 2023.
  • Autonomix Medical raised $2.4M (Seed) on May 17, 2023.

Who to call at BioVentrix, and when

A new round usually means BioVentrix is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BioVentrix raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioVentrix, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioVentrix. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BioVentrix

Location

120 FORBES BLVD.

Mansfield, Massachusetts, United States

About

BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Our mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive, catheter-based approaches.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BioVentrix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsDaniel S., Director of QualitySee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for BioVentrix's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

BioVentrix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.